| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.34 | 6e-13 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.33 | 4e-12 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-11 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-09 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |